We are live on
!
Find out more
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
35 hedge funds and large institutions have $5.35M invested in Novelion Therapeutics Inc. Common Shares in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more funds holding
Funds holding: 35 → 35 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
22% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 9
38% less capital invested
Capital invested by funds: $8.63M → $5.35M (-$3.28M)
46% less call options, than puts
Call options by funds: $46K | Put options by funds: $85K
Holders
35
Holders Change
–
Holders Change %
0%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
5
Increased
7
Reduced
9
Closed
5
Calls
$46K
Puts
$85K
Net Calls
-$39K
Net Calls Change
-$105K
Top Buyers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$546K |
| 2 |
EIG
EdgePoint Investment Group
Toronto,
Ontario, Canada
|
+$456K |
| 3 |
Goldman Sachs
New York
|
+$288K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$53.6K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$34.7K |
Top Sellers
| 1 |
BC
Broadfin Capital
New York
|
-$897K |
| 2 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$389K |
| 3 |
AG
Artal Group
Luxembourg
|
-$315K |
| 4 |
Millennium Management
New York
|
-$42.7K |
| 5 |
BlackRock
New York
|
-$42.1K |
